Navigation Links
Nordstrom Beat the Bridge to Beat Diabetes Run to Temporarily Suspend Traffic in University District on Sunday, May 17
Date:5/13/2009

SEATTLE, May 13 /PRNewswire-FirstCall/ -- On Sunday, May 17, traffic near the University of Washington and Montlake Bridge in Seattle will be temporarily suspended for the 27th annual Nordstrom Beat the Bridge to Beat Diabetes 8K run, which benefits the Juvenile Diabetes Research Foundation.

Montlake Closures

From 7:30 a.m. until 10:00 a.m., Montlake Boulevard will be closed from NE Pacific Street to 44th Avenue NE.

520 Ramp Closures

From 8:15 a.m. until 9:00 a.m., both Eastbound and Westbound off-ramps to 520 at Montlake will be closed.

Bridge Closures

The Montlake Bridge will close from 8:15 a.m. until 9:00 a.m. The University Bridge will close from 8:40 a.m. until 9:10 a.m. Both bridges will be closed to road and waterway traffic.

Boyer Avenue Closure and Pacific Avenue Traffic Delay

Boyer Avenue East in both directions from Lynn Street to University Bridge will be closed from 8:20 a.m. until 9:10 a.m. There will be additional traffic delays on Pacific Avenue from 8:15 a.m. until 10:00 a.m.

Visitors to the University of Washington campus during the aforementioned times should expect limited parking and possible delays as there are additional race routes that take participants through the campus. This year's Nordstrom Beat the Bridge to Beat Diabetes events are expected to attract over 9,000 participants and spectators. For additional race information, call (206) 628-1000 or log on to http://beatthebridge.org.

    CONTACT:  Kendall Ault
              Nordstrom, Inc.
              (206) 373-3031

(Logo: http://www.newscom
'/>"/>

SOURCE Nordstrom, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. INTERMACS: Total Artificial Heart Bridge-to-Transplant Rate 2x Higher at 6 Months Than BiVADS and LVADs
2. Isolagen Receives Bridge Financing to Allow it to Seek Debtor-in-Possession Financing in Connection With a Possible Filing Under Chapter 11 of the United States Bankruptcy Code
3. Haemacure Signs Term Sheet for Proposed Collaboration and Bridge Financing
4. Cambridge Employee Benefits to Host Corporate Wellness & HR Summit
5. Bridgegate Medical Center - Abuja, Nigeria
6. Lionbridge Announces Partnership with Open Text to Streamline Regulatory Compliance Solutions for Pharmaceutical Companies
7. The Methuselah Foundation Co-Sponsors My Bridge 4 Life and Tips 4 Life
8. Upcoming Symposium to Bridge the Gap between Osteoporosis Research and its Applications to Clinical Practice with Focus on Secondary Osteoporosis, Osteoporosis in Men, and Lessons from Space Travel for Improving Bone Health
9. AAHAM and BridgeFront Partner to Offer CPAT Preparatory Online Education
10. EMD Serono, Inc. Announces Expansion with Research Site in Cambridge, Massachusetts
11. Blue Cross and Blue Shield of Texas Sponsors Bridges to Excellence Program, Focusing on Quality Management of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... new study by researchers from the Medical College of ... utilization for pain and other sickle cell disease complications ... of both providers and patients were also identified. ... assistant professor of pediatrics at the Medical College and ... will be presented at the American Society of Hematology ...
(Date:12/6/2009)... new study provides welcome news for patients with a ... , The condition is estimated to impact 62,000 Canadians ... abnormal clot forms in a vein and restricts the ... cases, the clot may detach from its point of ... causing a potentially fatal condition known as a pulmonary ...
(Date:12/5/2009)... in a phase 1/2 clinical trial that it ... patients newly diagnosed with multiple myeloma, a cancer of ... Dana-Farber Cancer Institute. , Partial responses or better were ... the drug combination in the multi-center study, with 74 ... the phase 2 population, reports Paul G. Richardson, MD, ...
(Date:12/5/2009)... Babies, This Type of Blood Cancer Is Most Challenging-- ... Pediatric oncologists have identified specific genes, dubbed partner ... often-fatal form of leukemia in infants. By more accurately ... which infants may benefit from particular treatments. ,, ...
(Date:12/5/2009)... Center helps companies develop and test their cleaning processes. The technology ... of industries and solve problems for customers relating to cleaning parts, ... ... 2009 -- Midbrook, Inc , a Jackson, MI-based company, is ...
Breaking Medicine News(10 mins):Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... According to a recent study conducted by researchers at ... lead to a rise of certain// chemicals in the ... brain and nerve cell damage. This increase of chemicals ... and symptoms of lasting neurological damage. ,This ...
... published in PLoS Medicine online says that the life expectancy ... an Asian-American woman may live// two decades longer than an ... evidence is really quite clear that most of the gap ... young and middle-aged adult men and women and most of ...
... Sreemathy today visited the community health centre at Vizhinjam and ... of viral fever//. ,"In Tamil Nadu, the number ... managed to prevent the fever spreading further along the coast," ... day in August, but on Saturday the number was just ...
... the safest pain medication? Many people with osteoarthritis ... the painkillers called COX-2 inhibitors// to increased heart ... from a COX-2 drug to other medications, including ... and naproxen. But although NSAIDs are effective at ...
... the positive influence of having a baby and its benefits ... this research seem to suggest that women who are childless ... lives and may even face early death. ,According ... age are 20% more likely to die than their contemporaries, ...
... saw the conclusion of the first of a wave of ... as Wyeth defended// its hormone replacement therapy Prempro against claims ... ,Zoe Littlepage, an attorney for plaintiff Linda Reeves, told the ... was negligent in not testing the drug and not knowing ...
Other Medicine News:Health News:Punch-Drunk Effect- Every blow matters 2
(Date:12/4/2009)... Dynatronics Corporation (Nasdaq: DYNT ) announced it ... equipment and rehab supplies to Benchmark Physical Therapy with ... "We are pleased to be named the sole-source supplier ... vice president of sales and marketing at Dynatronics. "Benchmark ...
(Date:12/4/2009)... Chemistry World recently highlighted a new ... of America ( PhRMA ) that identifies 97 new ... ,, The report found that the 97 products ... are either in human clinical trials or awaiting approval by ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a ... chemical threats, announced today that the Company is ... of Valortim® in an inhalation anthrax model in ... data are being presented during an oral session ...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Pumgo Fitness Scooter Will Highlight Venice Beach This Summer 49639 1Pumgo Fitness Scooter Will Highlight Venice Beach This Summer 49639 2Crown Consumer Brands Re Launches DentaBurst 28TM 29 Freshening Teeth Cleaners 49636 1Crown Consumer Brands Re Launches DentaBurst 28TM 29 Freshening Teeth Cleaners 49636 2MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang 21 49633 1MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang 21 49633 2
... studies are few, NEW YORK, Aug. 13 ... a limited amount of clinical research exists,to prove ... study is published in the July/August 2007 issue ... of the,American Society for Aesthetic Plastic Surgery (ASAPS). ...
... Aug. 14 Immtech Pharmaceuticals,Inc. (Amex: IMM ... in Nucleic,Acids Research by a group of researchers ... furamidine to inhibit a key enzyme involved in ... the active metabolite (DB75),of Immtech,s proprietary, orally bioavailable ...
Other Medicine Technology:OTC Anti-Aging Products: Hype or Hope? 2Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 2Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: